Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reich

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Plos One|June 1, 2011
Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1Velasco Cimica, Hui-Chen Chen, Janaki K Iyer, et al.
Annals of the New York Academy of Sciences|November 27, 1995
Immunological properties of bacterial DNAD S Pisetsky, C Reich, S D Crowley, et al.
Genes and Immunity|December 21, 2007
IRF-3-dependent and augmented target genes during viral infectionJ Andersen, S VanScoy, T-F Cheng, et al.
Mechanisms of Development|June 1, 2005
A novel functional activator of the Drosophila JAK/STAT pathway, unpaired2, is revealed by an in vivo reporter of pathway activationM Melissa Gilbert, Brian K Weaver, J Peter Gergen, et al.
The Journal of Biological Chemistry|August 8, 1997
Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3M Martinez-Moczygemba, M J Gutch, D L French, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 23, 2009
[Does dilution have an impact on cosmetic results with BoNT/A? Complex-protein-free BoNT/A for treatment of glabella lines]W Prager, I Zschocke, C Reich, et al.
Dermatology (Basel, Switzerland)|May 3, 2008
Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaireM Augustin, A I Gajur, C Reich, et al.
JAMA Dermatology|January 24, 2017
A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell CarcinomasLauren R Becker, Angela E Aakhus, Hilary C Reich, et al.
Journal of American College Health : J of ACH|November 12, 2024
Examining the link between exercise motivation and preferred exercise setting in college studentsAmelia C Huelskamp, Lenis P Chen-Edinboro, Jessica C Reich, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|October 1, 1986
[Results of 4 years' use of oxytocin and prostaglandins F2 alpha for ripening with postterm indications after the 41st week of amenorrhea]Y C Reich, D Collin, I Menger, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Plos One|June 1, 2011
Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1Velasco Cimica, Hui-Chen Chen, Janaki K Iyer, et al.
Annals of the New York Academy of Sciences|November 27, 1995
Immunological properties of bacterial DNAD S Pisetsky, C Reich, S D Crowley, et al.
Genes and Immunity|December 21, 2007
IRF-3-dependent and augmented target genes during viral infectionJ Andersen, S VanScoy, T-F Cheng, et al.
Mechanisms of Development|June 1, 2005
A novel functional activator of the Drosophila JAK/STAT pathway, unpaired2, is revealed by an in vivo reporter of pathway activationM Melissa Gilbert, Brian K Weaver, J Peter Gergen, et al.
The Journal of Biological Chemistry|August 8, 1997
Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3M Martinez-Moczygemba, M J Gutch, D L French, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 23, 2009
[Does dilution have an impact on cosmetic results with BoNT/A? Complex-protein-free BoNT/A for treatment of glabella lines]W Prager, I Zschocke, C Reich, et al.
Dermatology (Basel, Switzerland)|May 3, 2008
Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaireM Augustin, A I Gajur, C Reich, et al.
JAMA Dermatology|January 24, 2017
A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell CarcinomasLauren R Becker, Angela E Aakhus, Hilary C Reich, et al.
Journal of American College Health : J of ACH|November 12, 2024
Examining the link between exercise motivation and preferred exercise setting in college studentsAmelia C Huelskamp, Lenis P Chen-Edinboro, Jessica C Reich, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|October 1, 1986
[Results of 4 years' use of oxytocin and prostaglandins F2 alpha for ripening with postterm indications after the 41st week of amenorrhea]Y C Reich, D Collin, I Menger, et al.
Pageof 16